GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Total Assets

EZZ Life Science Holdings (ASX:EZZ) Total Assets : A$29.74 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Total Assets?

EZZ Life Science Holdings's Total Assets for the quarter that ended in Dec. 2024 was A$29.74 Mil.

During the past 12 months, EZZ Life Science Holdings's average Total Assets Growth Rate was 28.30% per year. During the past 3 years, the average Total Assets Growth Rate was 27.00% per year.

During the past 5 years, EZZ Life Science Holdings's highest 3-Year average Total Assets Growth Rate was 27.00%. The lowest was 5.70%. And the median was 16.35%.

Total Assets is connected with ROA %. EZZ Life Science Holdings's annualized ROA % for the quarter that ended in Dec. 2024 was 23.13%. Total Assets is also linked to Revenue through Asset Turnover. EZZ Life Science Holdings's Asset Turnover for the quarter that ended in Dec. 2024 was 1.10.

EZZ Life Science Holdings Total Assets Historical Data

The historical data trend for EZZ Life Science Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Total Assets Chart

EZZ Life Science Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Total Assets
11.63 12.04 14.27 17.64 25.55

EZZ Life Science Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Assets Get a 7-Day Free Trial 14.98 17.64 20.30 25.55 29.74

EZZ Life Science Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

EZZ Life Science Holdings's Total Assets for the fiscal year that ended in Jun. 2024 is calculated as

Total Assets=Total Equity (A: Jun. 2024 )+Total Liabilities (A: Jun. 2024 )
=21.323+4.229
=25.55

EZZ Life Science Holdings's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (Q: Dec. 2024 )+Total Liabilities (Q: Dec. 2024 )
=24.038+5.704
=29.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EZZ Life Science Holdings  (ASX:EZZ) Total Assets Explanation

Total Assets is connected with ROA %.

EZZ Life Science Holdings's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %=Net Income (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=6.396/( (25.552+29.742)/ 2 )
=6.396/27.647
=23.13 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

EZZ Life Science Holdings's Asset Turnover for the quarter that ended in Dec. 2024 is

Asset Turnover
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=30.288/( (25.552+29.742)/ 2 )
=30.288/27.647
=1.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

EZZ Life Science Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

EZZ Life Science Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Total Assets
Comparable Companies
ASX:RCE ASX:PIQ ASX:AGN ASX:NUZ ASX:ATH ASX:LTP ASX:ACW ASX:RAD ASX:TYP ASX:SPL VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
55-59 Parramatta Road, Shop 1, Lidcombe, NSW, AUS, 2141
Website
https://www.ezzlife.com.au
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings Headlines

No Headlines